Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
Stock
ALNY
ALNY News & Events
-
Add to Watchlist
Trade ALNY
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Stock Price Prediction
Technical
Valuation
Financials
Earnings
Should I Buy
News & Events
ALNY Stock News Today | Earnings, Events & Price Alerts
ALNY News
Alnylam Pharmaceuticals Rated as One of the Unstoppable Stocks to Buy for Next 3 Years
1d ago
Yahoo Finance
Shifting Trends in Biotechnology Mergers and Acquisitions
Feb 19 2026
Globenewswire
Alnylam Pharmaceuticals Price Target Downgrade Analysis
Feb 19 2026
Yahoo Finance
Analysts Bullish on Alnylam Stock Outlook
Feb 17 2026
Fool
Alnylam Pharmaceuticals Reports Mixed Q4 and 2025 Results
Feb 13 2026
NASDAQ.COM
Alnylam Pharmaceuticals Reports Strong 2025 Earnings Despite Stock Decline
Feb 13 2026
Fool
ALNYLAM PHARMACEUTICALS INC PROJECTS FY TOTAL NET PRODUCT REVENUE BETWEEN $4.9 BILLION AND $5.3 BILLION
Feb 12 2026
moomoo
Alnylam Pharmaceuticals Q4 Earnings Miss Expectations
Feb 12 2026
seekingalpha
Show More News
ALNY Events
No data
ALNY Monitor News
Alnylam Pharmaceuticals Reports Mixed Q4 and 2025 Results
Feb 17 2026
Alnylam Pharmaceuticals Q4 Earnings Miss Expectations
Feb 12 2026
Alnylam Pharmaceuticals shows strong sales growth potential for 2026
Jan 20 2026
Alnylam Pharmaceuticals Projects Significant Revenue Growth by 2026
Jan 12 2026
Alnylam Pharmaceuticals falls amid broader market weakness
Jan 08 2026
Alnylam Pharmaceuticals rises on market strength
Jan 07 2026
Alnylam Pharmaceuticals hits a 20-day low amid market strength
Jan 05 2026
Alnylam Pharmaceuticals hits a 20-day low amid market decline
Dec 12 2025
Show More Monitor News
ALNY Earnings Analysis
Resilient Growth and Strategic Advances over Year - Intellectia AI™
1 years ago
Alnylam Pharmaceuticals Reports Third Quarter 2024 Financial Results
1 years ago
People Also Watch
